3-Cyano-4-fluorobenzaldehyde o-methyloxime 、 氰基硼氢化钠 、 以gave the title hydroxylamine as a clear oil after chromatography on silica gel (elution hexane-ethyl acetate 8: 2) (73% yield)的产率得到N-(3-cyano-4-fluorobenzyl)-O-methyl-hydroxylamine
2-氟-5-甲酰基苯腈 、 甲氧基胺盐酸盐 、 以gave the title oxime ether as a clear oil after chromatography on silica gel (elution hexane-ethyl acetate 8:2) (94% yield)的产率得到3-Cyano-4-fluorobenzaldehyde o-methyloxime
The present invention relates to the inhibition of HIV integrase, and to the treatment of AIDS or ARC by administering compounds of the following formula, or a tautomer of said compound, or a pharmaceutically acceptable salt, solvate or prodrug thereof:
1
wherein R
1
, R
2
and B
1
are as defined herein.
The present invention describes novel compounds of Formula I which inhibit HIV integrase. The invention also describes compositions and treatments of AIDS or ARC by using these compounds.
1